That which does not kill me makes me stronger; combining ERK1/2 pathway inhibitors and BH3 mimetics to kill tumour cells and prevent acquired resistance. (2013)

First Author: Sale MJ
Attributed to:  How does ERK1/2-dependent phosphorylation target BimEL to the proteasome? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.12220

PubMed Identifier: 23647573

Publication URI: http://europepmc.org/abstract/MED/23647573

Type: Journal Article/Review

Volume: 169

Parent Publication: British journal of pharmacology

Issue: 8

ISSN: 0007-1188